sinc
outbreak
mani
effort
made
engin
new
drug
find
way
fight
pandem
write
letter
focu
everybodi
attent
possibl
viabl
strategi
find
new
drug
therapeut
compound
describ
viru
cycl
infect
show
phase
possibl
compound
therapeut
use
adhes
viral
entri
first
phase
consist
membran
interact
host
cell
viru
allow
receptor
cleavag
activ
sarrscov
spike
protein
host
cell
proteas
essenti
viral
entri
host
cell
proteas
call
potenti
vitro
proven
inhibitor
camostat
mesyl
endocytosi
second
phase
allow
viru
insid
host
cell
one
known
regul
endocytosi
protein
kinas
use
artifici
intellig
possibl
find
good
inhibitor
like
baricitinib
known
janu
kinas
inhibitor
reduc
viral
entri
inflamm
patient
anoth
option
alter
endocytosi
process
hydroxychloroquin
deriv
chloroquin
alter
ph
increas
endosom
lysosom
essenti
membran
fusion
host
cell
viru
vitro
experi
show
chloroquin
treat
cell
endosom
vesicl
abnorm
enlarg
indic
alter
matur
process
endosom
block
endocytosi
result
failur
transport
virion
replic
site
show
rel
higher
mortal
rate
coronavirus
might
suggest
inflammatori
respons
might
play
role
pathogenesi
case
target
coronaviru
alon
antivir
therapi
might
enough
revers
highli
pathogen
infect
among
sarscov
structur
protein
n
e
nucleocapsid
protein
n
significantli
induc
activ
promotor
human
airway
epitheli
cell
cultur
gene
express
activ
n
protein
bind
nfkb
regulatori
element
promot
facilit
transloc
cytosol
nucleu
n
protein
essenti
secret
happen
sinc
delet
cterminu
n
protein
result
loss
function
activ
show
high
level
directli
induc
besid
also
associ
extens
lung
injuri
make
good
therapeut
target
drug
like
tocilizumab
known
inhibitor
free
circul
target
viral
compon
spike
protein
viru
specif
antibodi
anoth
therapeut
option
happen
free
circul
viru
coronavirus
neutral
antibodi
usual
target
spike
protein
viral
surfac
viru
allow
enter
host
cell
protein
two
subunit
one
mediat
cell
bind
one
mediat
cell
fusion
domain
neutral
antibodi
shown
target
receptor
interact
site
subunit
latest
develop
antibodi
show
neutral
properti
human
antibodi
shown
target
receptor
bind
domain
sarss
despit
capac
inhibit
infect
cell
sarss
bind
activ
compet
receptor
seem
indic
neutral
sarscov
yet
unknown
mechan
differ
bind
interfer
studi
show
despit
high
capabl
viru
mutat
target
conserv
core
structur
receptor
good
strategi
also
provid
evid
design
vaccin
compos
viral
structur
protein
like
protein
conclus
show
phase
viru
cycl
possibl
target
show
promis
target
aim
shed
light
futur
drug
therapi
need
engin
futur
come
author
declar
conflict
interest
